Jounce Therapeutics (JNCE) PT Lowered to $15 at Baird
Tweet Send to a Friend
Baird lowered its price target on Jounce Therapeutics (NASDAQ: JNCE) to $15.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
